Catalyst Wire Dossier Catalyst Wire Dossier

TDV (Takeda's tetravalent dengue vaccine candidate)

Tetravalent dengue vaccine candidate · Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TDV (Takeda's tetravalent dengue vaccine candidate), covering 2020-02-24 to 2020-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants [Phase 2]

See pricing